CClinicalTrials.gg
CompletedNCT06886867Updated Sep 16, 2026

Comparing Exergaming and Usual Care Physical Therapy in Nursing Home Residents

An interventional study of Exergaming and Usual physical therapy care in Older Adults Institutionalized in Residential Homes, sponsored by University of Castilla-La Mancha. Completed at 5 sites in Spain. Open to participants aged 60 Years to 105 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by University of Castilla-La Mancha · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
60 Years to 105 Years
Sex
All
01

Study summary

The objective of this clinical trial is to compare the effects of exergaming and usual care physical therapy on physical function in older adults residing in nursing homes.

This trial seeks to answer the following key questions:

  • Does physical function differ between interventions after treatment?
  • How do these interventions impact enjoyment of therapy?
  • Are there differences in adherence or perceived exertion between the interventions?
Read the detailed description

A single-blind, randomized controlled trial will be conducted to compare exergaming and usual care interventions. Participants will be recruited from nursing homes in the province of Toledo, and the study will follow the CONSORT guidelines for clinical, crossover, and parallel trials.

Two experimental groups will be tested, with interventions performed three days per week for six weeks, each session lasting approximately 30 minutes. The exergaming group will play seven video games from the Party Fowl app, while the usual care group will continue their standard exercise routine.

Outcome measures will be assessed at baseline, post-intervention (6 weeks), and at a 3-month follow-up to evaluate the middle-term effects of both interventions.

02

Conditions studied

  • Older Adults Institutionalized in Residential Homes
03

In context

Lead sponsor

University of Castilla-La Mancha is the lead sponsor of 104 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 105 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • subjects over 60 years of age
  • score equal to or greater than 20 on the Mini Mental cognitive test
  • Subjects that present the ability to stand without the use of technical aids or with the technical assistance of a device used for walking.

Exclusion criteria

Exclusion Criteria:

  • severe visual impairment
  • medical contraindication for physical activity
  • pathology or problem that could prevent the test from being carried out.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
78 participants (actual)

Study arms

  • Experimental
    Exergaming

    This group will perform approximately 28 minutes of exergaming 3 times a week for 6 weeks

    Other: Exergaming

  • Active comparator
    Usual physical therapy care

    This group will perform their usual care exercises treatments for approximately 28 minutes for 3 times a week for 6 weeks

    Other: Usual physical therapy care

Interventions

  • OtherExergaming

    Exergaming: Participants will perform different exercises through videogames

  • OtherUsual physical therapy care

    Usual care: Different exercises will be performed

06

What researchers measure

Primary outcomes

  1. Physical function

    Physical function will be assessed using the Short Physical Performance Battery (SPPB)

    Time frame: Baseline, post-intervention (6 weeks) and 3 months follow-up.

Secondary outcomes

  1. Hand grip strength

    Hand grip strength will be assessed using a hand dynamometer.

    Time frame: Baseline, post-intervention (6 weeks) and 3 months follow-up.

  2. Exercise enjoyment

    This outcome will be measured Physical Activity Enjoyment Scale (PACES). Higher values indicate higher perceived satisfaction/ enjoyment.

    Time frame: Post-intervention (6 weeks)

  3. Rate of Perceived Exertion

    Rate of perceived exertion will be measured using Borg (RPE 1-10). Higher values indicate higher levels of perceived exertion

    Time frame: RPE will be measured inmediatley after the intervention

  4. Adherence

    Adherence will be measured by the percentage of sessions attended of each participant.

    Time frame: Through study completion (6 weeks), with a final adherence percentage calculated at the end of the intervention.

07

Study locations

5 sites
  • Residencia de Mayores VIVENS
    Añover de Tajo, Toledo 45250, Spain
  • Nueva Esperanza Nursing Home
    Fuensalida, Toledo 45510, Spain
  • Residencia Maranatha
    Magán, Toledo 45590, Spain
  • Residencial Montes de Toledo
    Manzaneque, Toledo 45460, Spain
  • Universidad de Castilla-La Mancha
    Toledo, Toledo 45071, Spain
08

References and documents

Individual participant data

Plan to share: Undecided — Data will be provided to other researchers if asked to the principal investigator

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06886867
Lead sponsor
University of Castilla-La Mancha
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Mar 5, 2025
Primary completion
Apr 30, 2026
Completion
Jul 30, 2026
Last update
Sep 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion